Form 4: CompoSecure Director Kevin Moriarty Opts for Stock Options Over Cash Retainer

CompoSecure, Inc. Director Kevin M. Moriarty was granted 6,998 stock options with a $13.8 exercise price, vesting over four years, in lieu of his annual $50,000 cash retainer.

Summary

• Kevin M. Moriarty, a Director of CompoSecure, Inc. (CMPO), was granted 6,998 stock options.
• The options have an exercise price of $13.8 per share.
• The grant date for these options was July 29, 2025, and they expire on July 29, 2035.
• These stock options will vest in equal annual installments of 25% each on July 29, 2026, July 29, 2027, July 29, 2028, and July 29, 2029.
• The options were issued under the Fifth Amended and Restated CompoSecure, Inc. Non-Employee Director Compensation Policy.
• Moriarty elected to receive these stock options in lieu of his annual cash retainer of $50,000.

Sentiment

Score: 7

Explanation: The grant of stock options to a director in lieu of cash compensation is generally a positive signal, indicating alignment of interests and confidence in future performance. It's a standard corporate governance practice.

Positives

• Director Kevin M. Moriarty elected to receive stock options instead of a cash retainer, aligning his interests more closely with shareholders.
• The grant of stock options at a $0 price (meaning they were compensation, not purchased) provides a long-term incentive for the director.
• The vesting schedule over four years encourages long-term commitment and performance from the director.

Future Outlook

NA

Industry Context

This transaction reflects a common practice in corporate governance where non-employee directors receive a portion of their compensation in equity to align their interests with shareholders. This is standard across many industries, particularly in technology and financial services where CompoSecure operates.

Comparison to Industry Standards

• Granting stock options to non-employee directors is a widely accepted compensation practice across publicly traded companies, including those in the financial technology and security sectors.
• The election by a director to receive equity in lieu of cash is often viewed favorably as it demonstrates confidence in the company's future performance and strengthens alignment with shareholder interests, similar to practices seen at companies like Visa, Mastercard, or other payment technology firms that emphasize long-term value creation.
• The vesting schedule of four years is typical for long-term incentive plans for directors, comparable to structures at many S&P 500 companies.

Corporate Governance

Related Party Transactions

• The grant of stock options to Kevin M. Moriarty, a Director of CompoSecure, Inc., constitutes a related party transaction as it involves compensation provided to a member of the company's board.

Stakeholder Impact

• Shareholders: Potential for minor dilution if options are exercised, but also increased alignment of director's interests with shareholder value.

Next Steps

• The stock options will vest in 25% annual installments on July 29, 2026, 2027, 2028, and 2029.
• The director may choose to exercise the options at any time after vesting and before the expiration date of July 29, 2035, assuming the stock price is above the exercise price of $13.8.

Key Dates

Recommendation

This Form 4 filing details a routine compensation event for a director, where stock options were granted in lieu of cash. While it signals alignment of interests, it does not provide new fundamental information about the company's financial performance, strategic direction, or market position that would warrant a change in investment recommendation. It's a neutral event from an investment decision perspective, reinforcing a "hold" stance for existing investors.

Keywords

CompoSecure, CMPO, Stock Options, Director Compensation, SEC Form 4, Insider Transaction, Equity Compensation, Corporate Governance